Lipitor vs. Zocor Article

November 16, 2005 on 5:08 pm | In Biomedical News |

An interesting article entitled “Mixed results for high-dose Lipitor vs. regular-dose Zocor” appeared in the San Diego Union-Tribune on November 15th. Check out the story…

See more on the story below.

“High doses of the cholesterol-lowering drug Lipitor were no better at preventing recurrent heart attacks and heart-related deaths than regular doses of the competing drug Zocor, according to the latest study on efforts to aggressively treat heart conditions.

The study, funded and conducted by Lipitor’s maker Pfizer Inc., was prepared for presentation Tuesday at an American Heart Association meeting in Dallas. It also appears in Wednesday’s Journal of the American Medical Association.”